Teresa DeLuca insider trades: Surgery Partners (SGRY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Teresa reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | SGRY | ↑ Buy | 11,250 | $14.33 | $161K | Direct | Aug 20, 2026 (2d) |
| Aug 18, 2026 | SGRY | ↑ Buy | 10,000 | $14.35 | $144K | Direct | Aug 19, 2026 (1d) |
| Aug 13, 2026 | LFST | ↓ Sell | 20,441 | $12.23 | $250K | Direct | Aug 14, 2026 (1d) |
| Aug 11, 2025 | SGRY | ↓ Sell | 20,018 | $22.74 | $455K | Direct | Aug 15, 2025 (4d) |
| Nov 21, 2022 | SGRY | ↑ Buy | 20,000 | $24.50 | $490K | Direct | Nov 22, 2022 (1d) |
| Mar 24, 2022 | SGRY | ↓ Sell | 1,535 | $53.50 | $82K | Direct | Mar 25, 2022 (1d) |
| Dec 9, 2021 | ATNF | ↑ Buy | 5,000 | $4.00 | $20K | Direct | Dec 13, 2021 (4d) |
| Dec 9, 2021 | ATNF | ↑ Buy | 5,000 | $3.98 | $20K | By Trust | Dec 13, 2021 (4d) |
| Dec 9, 2021 | ATNF | ↑ Buy | 2,500 | $3.95 | $10K | By Spouse | Dec 13, 2021 (4d) |
| Aug 10, 2021 | SGRY | ↑ Buy | 2,000 | $46.70 | $93K | Direct | Aug 12, 2021 (2d) |
| Jun 9, 2021 | SGRY | ↓ Sell | 5,035 | $63.67 | $321K | Direct | Jun 11, 2021 (2d) |
| Jun 8, 2021 | SGRY | ↓ Sell | 2,633 | $63.05 | $166K | Direct | Jun 9, 2021 (1d) |
| Dec 14, 2020 | SGRY | ↓ Sell | 1,000 | $27.15 | $27K | Direct | Dec 15, 2020 (1d) |
| Dec 4, 2020 | SGRY | ↓ Sell | 915 | $27.75 | $25K | Direct | Dec 7, 2020 (3d) |
| Sep 10, 2020 | SGRY | ↓ Sell | 3,000 | $21.00 | $63K | Direct | Sep 14, 2020 (4d) |
| Aug 10, 2020 | SGRY | ↓ Sell | 5,317 | $20.60 | $110K | Direct | Aug 11, 2020 (1d) |
| Sep 6, 2019 | SGRY | ↑ Buy | 1,000 | $6.65 | $7K | Direct | Sep 10, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SGRY insiders
Open-market trades in the last 12 months
About Teresa DeLuca's insider trades
Teresa DeLuca is a director at Surgery Partners (SGRY). Since Sep 6, 2019, Teresa has reported 8 open-market purchases worth $945K and 9 sales worth $1.5M on SEC Form 4. In the last 12 months: 2 buys ($305K) and 1 sale ($250K).
Their filings also include grants and awards (18 filings), option exercises (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGRY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.